Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03287648
Other study ID # 0004/2017
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date June 1, 2017
Est. completion date May 20, 2024

Study information

Verified date January 2021
Source University of Molise
Contact Roberto dell'Omo, Prof
Phone 00393317120416
Email roberto.dellomo@unimol.it
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Some alterations of the foveal contour do not meet the criteria established for the definition of lamellar macular hole on the basis of optical coherence tomography (OCT). However, these alterations may show an appearance, on blue fundus autofluorescence (B-FAF) imaging, reminiscent of lamellar macular hole. The aim of the study is to evaluate in detail these alterations recording simultaneously OCT and B-FAF.


Description:

All images will be collected using the Heidelberg Spectralis system (Heidelberg Engineering, Heidelberg, Germany) according to the prespecified imaging protocols. Blue-fundus autofluorescence (excitation wavelength at 488 nm and barrier filter at 500 nm) images and SD-OCT images will be obtained after pupil dilation. The OCT recording protocol will consist of a sequence of 37 horizontal sections, spaced 120-µm apart, covering an area of 20° or 30° horizontally by 15° vertically, and a sequence of 24 radial sections recorded in the high-resolution (HR) mode simultaneously with infrared (IR) images. In addition, simultaneous B-FAF/OCT images will be acquired (horizontal, and vertical OCT sections, centered on the fovea and recorded in the HR mode). The same OCT/FAF protocol will be used for the study eye and for the fellow eye. For the study eyes that had been examined in the past, the ''Follow-up'' function will be used in addition to the prespecified protocol to evaluate if any changes had occurred since the last scan. Multiple other morphological characteristics will be analyzed using OCT imaging, including the status of the posterior cortex, the presence of operculum, the integrity/disruption of the external limiting membrane (ELM), ellipsoid zone (EZ), and the central and minimal foveal thickness (CFT and mFT respectively). The latter will be defined as the thinnest part of the fovea within the foveal pit identified by examining radial scans whereas the former will be measured in relation to the highest point of the foveal bulge. All measurements will be performed using the Spectralis built-in manual caliper function at high magnification after adjusting the scale to 1:1 µm except for CFT, which will be calculated using the automated ''thickness map'' function of the Heidelberg Eye Explorer.


Recruitment information / eligibility

Status Recruiting
Enrollment 20
Est. completion date May 20, 2024
Est. primary completion date January 15, 2021
Accepts healthy volunteers No
Gender All
Age group 20 Years to 90 Years
Eligibility Inclusion Criteria: - alteration of the foveal contour not classifiable as lamellar or pseudo macular hole - focal, well-defined increased autofluorescence signal at the fovea Exclusion Criteria: - intraretinal cysts not associated with break of the inner retina - juxtafoveal telangiectasia - ring of increased B-FAF - vitelliform and pseudovitelliform lesions - history of diabetes, retinal vein occlusion, uveitis, CSR, AMD or any other retinal -disease potentially associated with intra or subretinal fluid - macular drusen - history of submacular hemorrhage

Study Design


Intervention

Diagnostic Test:
optical coherence tomography and blue-fundus autofluorescence
Simultaneous infra-red and optical coherence tomography (cube and radial pattern) centered on the fovea Simultaneous fundus autofluorescence and optical coherence tomography (radial pattern) centered on the fovea

Locations

Country Name City State
Italy University of Molise Campobasso

Sponsors (2)

Lead Sponsor Collaborator
University of Molise University of Milan

Country where clinical trial is conducted

Italy, 

Outcome

Type Measure Description Time frame Safety issue
Primary Relationship between OCT and B-FAF findings Measurements of the diameters of the holes expressed in microns, on OCT and B-FAF images respectively, will be collected. The topographic correlation between the area of increased B-FAF signal and the corresponding area on OCT, will be examined. 6 months
Secondary Relationship between OCT and B-FAF characteristics and logMAR visual acuity The relationship between central foveal thickness and logMAR visual acuity will be evaluated 6 months